Published in Int J Dev Neurosci on September 15, 2010
How might circadian rhythms control mood? Let me count the ways... Biol Psychiatry (2013) 1.95
Dendritic spine pathology in schizophrenia. Neuroscience (2012) 1.91
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry (2011) 1.85
OXPHOS mutations and neurodegeneration. EMBO J (2012) 1.33
Balancing histone methylation activities in psychiatric disorders. Trends Mol Med (2011) 1.14
Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis (2011) 1.11
Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology? Schizophr Res (2014) 1.06
Roles of heat shock factor 1 in neuronal response to fetal environmental risks and its relevance to brain disorders. Neuron (2014) 1.03
Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia. Neuropsychopharmacology (2012) 1.02
DISC1 genetics, biology and psychiatric illness. Front Biol (Beijing) (2013) 1.00
Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53. PLoS One (2012) 1.00
Measuring the maturity of the fast-spiking interneuron transcriptional program in autism, schizophrenia, and bipolar disorder. PLoS One (2012) 1.00
Intracellular and extracellular redox status and free radical generation in primary immune cells from children with autism. Autism Res Treat (2011) 0.99
Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression. BMC Bioinformatics (2011) 0.98
Neurodevelopment, GABA system dysfunction, and schizophrenia. Neuropsychopharmacology (2014) 0.96
Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach. World J Biol Psychiatry (2013) 0.93
Permeability transition pore-mediated mitochondrial superoxide flashes regulate cortical neural progenitor differentiation. PLoS One (2013) 0.90
Adult neurogenesis transiently generates oxidative stress. PLoS One (2012) 0.90
Oxidative stress in early stage Bipolar Disorder and the association with response to lithium. J Psychiatr Res (2013) 0.90
Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging. Schizophr Res (2012) 0.89
Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes. Can J Psychiatry (2016) 0.87
Schizophrenia as a disorder of molecular pathways. Biol Psychiatry (2014) 0.85
Transcriptome profiling of human hippocampus dentate gyrus granule cells in mental illness. Transl Psychiatry (2014) 0.85
Brain abnormalities in bipolar disorder detected by quantitative T1ρ mapping. Mol Psychiatry (2015) 0.85
Modeling mitochondrial dysfunctions in the brain: from mice to men. J Inherit Metab Dis (2011) 0.84
Upstream Pathways Controlling Mitochondrial Function in Major Psychosis: A Focus on Bipolar Disorder. Can J Psychiatry (2016) 0.84
Gray matter volumetric abnormalities associated with the onset of psychosis. Front Psychiatry (2012) 0.84
Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression. Transl Psychiatry (2014) 0.83
Bipolar disorder dynamics: affective instabilities, relaxation oscillations and noise. J R Soc Interface (2015) 0.82
Psychiatric symptoms of patients with primary mitochondrial DNA disorders. Behav Brain Funct (2012) 0.82
Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia. Mol Neuropsychiatry (2015) 0.81
Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes. Psychopharmacology (Berl) (2014) 0.81
Transcriptome Profiling of Peripheral Blood in 22q11.2 Deletion Syndrome Reveals Functional Pathways Related to Psychosis and Autism Spectrum Disorder. PLoS One (2015) 0.80
Bioenergetic measurements in children with bipolar disorder: a pilot 31P magnetic resonance spectroscopy study. PLoS One (2013) 0.80
Lithium reduces the effects of rotenone-induced complex I dysfunction on DNA methylation and hydroxymethylation in rat cortical primary neurons. Psychopharmacology (Berl) (2014) 0.80
Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis. BMC Genomics (2014) 0.79
DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond. Int J Mol Sci (2016) 0.79
Mitochondrial dysfunction in schizophrenia: an evolutionary perspective. Hum Genet (2014) 0.78
A composite peripheral blood gene expression measure as a potential diagnostic biomarker in bipolar disorder. Transl Psychiatry (2015) 0.78
The Potential Role of the NLRP3 Inflammasome as a Link between Mitochondrial Complex I Dysfunction and Inflammation in Bipolar Disorder. Neural Plast (2015) 0.78
Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects. Neuropsychiatr Dis Treat (2015) 0.77
Antimanic Treatment With Tamoxifen Affects Brain Chemistry: A Double-Blind, Placebo-Controlled Proton Magnetic Resonance Spectroscopy Study. Biol Psychiatry Cogn Neurosci Neuroimaging (2016) 0.77
Identification of the mitochondrial MSRB2 as a binding partner of LG72. Cell Mol Neurobiol (2014) 0.77
Proteomic analysis of lymphoblastoid cells derived from monozygotic twins discordant for bipolar disorder: a preliminary study. PLoS One (2013) 0.76
Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches. Oxid Med Cell Longev (2016) 0.76
Reduced mRNA expression of PTGDS in peripheral blood mononuclear cells of rapid-cycling bipolar disorder patients compared with healthy control subjects. Int J Neuropsychopharmacol (2014) 0.76
Identification of collaborative activities with oxidative phosphorylation in bipolar disorder. Bioinformation (2015) 0.76
Emergent treatments based on the pathophysiology of bipolar disorder: A selective review. Asian J Psychiatr (2015) 0.76
Altered coupling of regional cerebral blood flow and brain temperature in schizophrenia compared with bipolar disorder and healthy subjects. J Cereb Blood Flow Metab (2014) 0.76
mRNA changes in nucleus accumbens related to methamphetamine addiction in mice. Sci Rep (2016) 0.75
Disrupted in schizophrenia 1 (DISC1) is a constituent of the mammalian mitochondrial contact site and cristae organizing system (MICOS) complex, and is essential for oxidative phosphorylation. Hum Mol Genet (2016) 0.75
Neuroprotective Effects of Açaí (Euterpe oleracea Mart.) against Rotenone In Vitro Exposure. Oxid Med Cell Longev (2016) 0.75
Mitochondrion-toxic drugs given to patients with mitochondrial psychoses. Behav Brain Funct (2012) 0.75
Regional differences in mitochondrial DNA methylation in human post-mortem brain tissue. Clin Epigenetics (2017) 0.75
Physical Exercise for Treatment of Mood Disorders: A Critical Review. Curr Behav Neurosci Rep (2016) 0.75
Synaptic and cellular changes induced by the schizophrenia susceptibility gene G72 are rescued by N-acetylcysteine treatment. Transl Psychiatry (2016) 0.75
What Have Mass Spectrometry-Based Proteomics and Metabolomics (Not) Taught Us about Psychiatric Disorders? Mol Neuropsychiatry (2015) 0.75
Abnormalities in High-Energy Phosphate Metabolism in First-Episode Bipolar Disorder Measured Using (31)P-Magnetic Resonance Spectroscopy. Biol Psychiatry (2017) 0.75
Postmortem studies on mitochondria in schizophrenia. Schizophr Res (2017) 0.75
Omega-3 Fatty Acids and Mood Stabilizers Alter Behavioural and Energy Metabolism Parameters in Animals Subjected to an Animal Model of Mania Induced by Fenproporex. Mol Neurobiol (2016) 0.75
Methylene blue and its analogues as antidepressant compounds. Metab Brain Dis (2017) 0.75
Glutathione-mediated effects of lithium in decreasing protein oxidation induced by mitochondrial complex I dysfunction. J Neural Transm (Vienna) (2014) 0.75
The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence. Front Neurosci (2017) 0.75
Mitochondrial genetic haplogroups and depressive symptoms: A large study among people in North America. J Affect Disord (2017) 0.75
A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet (2005) 16.79
Mitochondrial diseases in man and mouse. Science (1999) 11.67
Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol (2003) 9.07
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci (1973) 7.85
How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol (2008) 6.02
Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry (2010) 5.27
Microdomains of intracellular Ca2+: molecular determinants and functional consequences. Physiol Rev (2006) 4.87
Cell death. N Engl J Med (2009) 4.75
Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet (2008) 4.71
Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci (2002) 4.36
Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum Mol Genet (2004) 4.11
Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull (2005) 3.93
MITOMAP: a human mitochondrial genome database--2004 update. Nucleic Acids Res (2005) 3.35
Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry (1991) 3.21
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A (2002) 3.11
Mitochondrial disorders in the nervous system. Annu Rev Neurosci (2008) 2.93
Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol (2005) 2.91
Mechanisms and consequences of somatic mosaicism in humans. Nat Rev Genet (2002) 2.85
A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry (1982) 2.75
Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes. Nat Genet (2000) 2.62
A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry (1998) 2.56
22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci (2010) 2.54
Psychiatric genetics: progress amid controversy. Nat Rev Genet (2008) 2.51
Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci U S A (1996) 2.50
Increased mitochondrial mass in mitochondrial myopathy mice. Proc Natl Acad Sci U S A (2002) 2.38
Mitochondrial dysfunction in bipolar disorder. Bipolar Disord (2000) 2.32
Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet (2004) 2.31
Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry (2004) 2.27
The functional organization of mitochondrial genomes in human cells. BMC Biol (2004) 2.20
High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J (2002) 2.18
Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse (1987) 2.08
Number matters: control of mammalian mitochondrial DNA copy number. J Genet Genomics (2009) 2.05
Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry (2005) 1.95
Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci U S A (2002) 1.92
Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry (2004) 1.89
Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull (2001) 1.86
Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci (2009) 1.85
A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions. Biol Psychiatry (2006) 1.82
Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet C Semin Med Genet (2003) 1.80
Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci (2002) 1.79
Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet (2006) 1.78
Abnormal cellular energy and phospholipid metabolism in the left dorsolateral prefrontal cortex of medication-free individuals with bipolar disorder: an in vivo 1H MRS study. Bipolar Disord (2007) 1.78
Mitochondrial DNA sequence diversity in bipolar affective disorder. Am J Psychiatry (2000) 1.77
Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem (1999) 1.77
Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol Psychiatry (2005) 1.76
Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series. Am J Hum Genet (2003) 1.66
The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord (2009) 1.62
Neurophysiological endophenotypes across bipolar and schizophrenia psychosis. Schizophr Bull (2008) 1.61
Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet (1995) 1.60
Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry (2002) 1.59
Molecular mechanisms of schizophrenia. Cell Physiol Biochem (2007) 1.53
Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Dev Psychopathol (2008) 1.48
Subtyping schizophrenia: implications for genetic research. Mol Psychiatry (2006) 1.44
Mitochondrial DNA in mortal and immortal human cells. Genome number, integrity, and methylation. J Biol Chem (1983) 1.41
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38
Mitochondrial involvement in psychiatric disorders. Ann Med (2008) 1.38
The Dutch Famine of 1944-1945: a pathophysiological model of long-term consequences of wasting disease. Curr Opin Clin Nutr Metab Care (2006) 1.37
Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One (2009) 1.36
Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord (2002) 1.36
Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry (2010) 1.36
Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria. Mol Cell Neurosci (2004) 1.35
Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol Psychiatry (2007) 1.32
The evolution of drug development in schizophrenia: past issues and future opportunities. Neuropsychopharmacology (2007) 1.31
Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Mol Psychiatry (2006) 1.31
Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium. Brain Res (2001) 1.30
Susceptibility loci for bipolar disorder: overlap with inherited vulnerability to schizophrenia. Biol Psychiatry (2000) 1.30
Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology (2008) 1.29
Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology (2010) 1.25
A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: implications for clinical evaluation and treatment. Curr Psychiatry Rep (2007) 1.22
Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics (2005) 1.21
Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry (2006) 1.19
Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol (2010) 1.19
Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population. Schizophr Res (2006) 1.18
Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Mol Psychiatry (2007) 1.18
Schizophrenia and bipolar disorder: differences and overlaps. Curr Opin Psychiatry (2006) 1.17
Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One (2008) 1.17
Abnormalities of glucose metabolism associated with atypical antipsychotic drugs. J Clin Psychiatry (2004) 1.15
Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biol Psychiatry (2008) 1.14
Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res (2001) 1.14
Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J Affect Disord (1993) 1.14
Creatine abnormalities in schizophrenia and bipolar disorder. Psychiatry Res (2009) 1.11
Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol Ther (2003) 1.11
Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2003) 1.11
Dopamine inhibits mitochondrial motility in hippocampal neurons. PLoS One (2008) 1.11
Disrupted in schizophrenia 1 (DISC1): subcellular targeting and induction of ring mitochondria. Mol Cell Neurosci (2005) 1.10
Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8. Hum Mol Genet (2004) 1.08
Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study. Biol Psychiatry (2004) 1.08
Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Arch Gen Psychiatry (2007) 1.08
Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse (1999) 1.07
Mitochondrial localization and function of a subset of 22q11 deletion syndrome candidate genes. Mol Cell Neurosci (2008) 1.06
Populations of hippocampal inhibitory neurons express different levels of cytochrome c. Eur J Neurosci (2006) 1.06
Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem (2002) 1.06
Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia. Eur Neuropsychopharmacol (2007) 1.03
Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord (1994) 1.02
Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: further support for the involvement of mitochondrial function in anxiety disorders. Behav Brain Res (2005) 1.02
Subcellular targeting of DISC1 is dependent on a domain independent from the Nudel binding site. Mol Cell Neurosci (2005) 1.01
Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro. Arch Pharm Res (2003) 1.01
Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol Psychiatry (2005) 1.01
State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol Psychiatry (2002) 1.01
Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder. Biol Psychiatry (1997) 1.00
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Biol Psychiatry (2007) 1.65
Hippocampal pathology in schizophrenia. Curr Top Behav Neurosci (2010) 1.43
Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors. Neuropsychopharmacology (2008) 1.38
Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biol Psychiatry (2011) 1.33
Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J Neurochem (2003) 1.29
Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. J Neurochem (2004) 1.25
Maladaptive striatal plasticity in L-DOPA-induced dyskinesia. Prog Brain Res (2010) 1.23
Altered attention and prefrontal cortex gene expression in rats after binge-like exposure to cocaine during adolescence. J Neurosci (2006) 1.22
Brain reward regulated by AMPA receptor subunits in nucleus accumbens shell. J Neurosci (2006) 1.17
Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Neuropharmacology (2004) 1.09
Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Arch Gen Psychiatry (2007) 1.08
Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue. Mol Pharmacol (2008) 1.08
Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia. Brain (2011) 1.01
Bipolar disorder type 1 and schizophrenia are accompanied by decreased density of parvalbumin- and somatostatin-positive interneurons in the parahippocampal region. Acta Neuropathol (2011) 1.00
Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord (2006) 0.95
Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat. Biol Psychiatry (2005) 0.94
Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum. J Neurochem (2003) 0.91
Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats. Schizophr Res (2009) 0.87
Binge cocaine administration in adolescent rats affects amygdalar gene expression patterns and alters anxiety-related behavior in adulthood. Biol Psychiatry (2011) 0.84
Mitochondrial abnormalities in the putamen in Parkinson's disease dyskinesia. Acta Neuropathol (2010) 0.81
Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences. J Neurosci (2006) 0.81
Myelin, copper, and the cuprizone model of schizophrenia. Front Biosci (Schol Ed) (2011) 0.79
L-type Ca2+ channel blockers promote Ca2+ accumulation when dopamine receptors are activated in striatal neurons. Brain Res Mol Brain Res (2004) 0.78
Substantia nigra hyperactivity in schizophrenia. Biol Psychiatry (2013) 0.76
Effects of naloxone-precipitated morphine withdrawal on glutamate-mediated signaling in striatal neurons in vitro. Ann N Y Acad Sci (2003) 0.75